Show simple item record

dc.contributor.authorKralt, Braden
dc.date.accessioned2020-01-24 19:12:02 (GMT)
dc.date.available2021-01-24 05:50:06 (GMT)
dc.date.issued2020-01-24
dc.date.submitted2020-01-23
dc.identifier.urihttp://hdl.handle.net/10012/15577
dc.description.abstractDaptomycin is a calcium-dependent cyclic lipodepsipeptide that is used clinically in the treatment of infections caused by pathogenic Gram-positive organisms, such as methicillin-resistant Staphylococcus aureus. Another calcium-dependent cyclic lipodepsipeptide antibiotic, A54145D, also has biological activity against Gram-positive pathogenic organisms, but is not used clinically because it is approximately 4-fold less active than daptomycin. Unlike daptomycin, however, A54145D is not inhibited by lung surfactant in vitro, which makes A54145D a suitable lead compound for the development of other antibiotics that may find use in medical practice as an alternative treatment for community-acquired pneumonia caused by Streptococcus pneumoniae. While the total synthesis of daptomycin has been reported, thus allowing for an efficient method for the generation of analogs of daptomycin, no similar synthesis for A54145D was reported at the start of these studies. To facilitate the development of future antibiotics, a total synthesis of A54145D was developed employing Fmoc-based solid-phase-peptide synthesis. This synthesis enabled us to confirm that the 3-hydroxyasparagine residue has the (2S,3S)-configuration (threo), and the 3-methoxyaspartate residue has the (2S,3R)-configuration (erythro) instead of the (2S,3S)-configuration (threo). Additional analogs of A54145D and A54145A¬1 were synthesized to study the structure-activity relationships of these antibiotics, and it was determined that the threonine residue is not amenable for substitution, in that replacement of threonine caused a dramatic loss in biological activity. Furthermore, it was confirmed that the replacement of the uncommon amino acid 3-methoxyaspartate with aspartate, and 3-hydroxyasparagine with asparagine resulted in a 16-fold reduction of biological activity. To further elucidate the mechanism of action of cyclic lipodepsipeptide antibiotics, which is a matter of some controversy in the scientific literature, ten fluorinated analogs of daptomycin were constructed by semi-synthesis or total synthesis to study their interaction with model membranes using 19F-NMR. These analogs exhibited activity against Bacillus subtilis equal to or approaching that of daptomycin. 19F-NMR studies with a peptide that contained a trifluoromethyl moiety at the end of the lipid tail indicate that at concentrations of daptomycin and calcium that are representative of in vivo conditions, daptomycin does not aggregate in solution. Preliminary 19F-NMR studies with a daptomycin analog containing the CF3 group appended to the ornithine residue at position 6 in the presence of model membranes and varying amounts of calcium suggest that the ornithine residue of daptomycin interacts with biological membranes before the lipid tail does.en
dc.language.isoenen
dc.publisherUniversity of Waterlooen
dc.subjectdaptomycinen
dc.subjectA54145en
dc.subjecttotal synthesisen
dc.subject19F-NMRen
dc.subjectcyclic lipodepsipeptidesen
dc.subjectantibioticsen
dc.titleLipodepsipeptide Antibiotics: Total Synthesis and Mechanism of Action Studies Using 19F-NMRen
dc.typeDoctoral Thesisen
dc.pendingfalse
uws-etd.degree.departmentChemistryen
uws-etd.degree.disciplineChemistryen
uws-etd.degree.grantorUniversity of Waterlooen
uws-etd.degreeDoctor of Philosophyen
uws-etd.embargo.terms1 yearen
uws.contributor.advisorTaylor, Scott
uws.contributor.affiliation1Faculty of Scienceen
uws.published.cityWaterlooen
uws.published.countryCanadaen
uws.published.provinceOntarioen
uws.typeOfResourceTexten
uws.peerReviewStatusUnrevieweden
uws.scholarLevelGraduateen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record


UWSpace

University of Waterloo Library
200 University Avenue West
Waterloo, Ontario, Canada N2L 3G1
519 888 4883

All items in UWSpace are protected by copyright, with all rights reserved.

DSpace software

Service outages